![\"Prescription](\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2026\/04\/7ed84cc89c86fb7a72ee514336f8b319.jpeg\"\/)
<\/p>\n<\/p>\n
Prescription Medication Medicine Pill Tablets
Credit: Getty<\/p>\n
NEED TO KNOW<\/p>\n
One type of the prescription anxiety medication Xanax is being recalled nationwide<\/p>\n<\/li>\n
3 mg tablets of the medication, sold in 60-tablet bottles, were initially recalled by its distributor, Viatris, on March 17. On April 15, the tablets were recalled nationwide<\/p>\n<\/li>\n
The affected medication was prescribed and distributed between Aug. 27, 2024 and May 29, 2025<\/p>\n<\/li>\n<\/ul>\n
One type of the commonly prescribed prescription anxiety medication Xanax has been recalled<\/a> nationwide, according to the Food and Drug Administration (FDA<\/a>).<\/p>\n 3-milligram tablets of Xanax XR, the brand name for the drug alprazolam, sold in 60-tablet bottles were initially recalled by the distributor Viatris on March 17. On Wednesday, April 15, the pills were recalled nationwide after they “failed dissolution specifications,” according to the FDA.<\/p>\n The FDA classified the recall as a Class II, indicating “a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” per the agency.<\/p>\n Pills marked as part of lot number 8177156 are impacted by the recall. The medication will be marked with an expiration date of 02\/28\/2027.<\/p>\n Anyone who has been prescribed the affected pills should stop taking them immediately, and dispose<\/a> of them safely.<\/p>\n FDA Sign The pills were distributed to patients between Aug 27, 2024, and May 29, 2025, per the California State Board of Pharmacy<\/a>.<\/p>\n Xanax is typically prescribed to treat symptoms of anxiety associated with several mental health conditions. “It works by helping your nervous system calm down,” per Cleveland Clinic<\/a>. It is one of the most commonly prescribed benzodiazepines in the U.S.<\/p>\n Never miss a story \u2014 sign up for\u00a0<\/strong>PEOPLE’s free daily newsletter<\/strong><\/a>\u00a0to stay up-to-date on the best of what PEOPLE has to offer\u200b\u200b, from celebrity news to compelling human-interest stories.<\/strong><\/p>\n PEOPLE has reached out to a representative for Viatris for comment.<\/p>\n![\"FDA](\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2026\/04\/0ea356d4de886acaa7754277e7385faa.jpeg\"\/)
<\/p>\n
Credit: Sarah Silbiger\/Getty<\/p>\n